This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Bayer Pharma Aktiengesellschaft. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Michael Formell: Innovator in Pharmaceutical Dosage Forms
Introduction
Michael Formell is a notable inventor based in Glienicke, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. His work focuses on improving the efficacy and safety of medications.
Latest Patents
Michael Formell holds a patent for a pharmaceutical dosage form comprising sodium-1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazol-1-yl)-1H-pyrazol-5-olate. This invention relates to solid pharmaceutical dosage forms for oral administration, characterized by the release of the active ingredient. The patent outlines methods for preparation and use as medicaments, particularly for treating cardiovascular disorders, heart failure, anemia, chronic renal disorders, and renal insufficiency. He has 1 patent to his name.
Career Highlights
Michael Formell is currently employed at Bayer Pharma Aktiengesellschaft, a leading global pharmaceutical company. His role involves research and development of innovative pharmaceutical solutions that address critical health issues.
Collaborations
Michael has collaborated with esteemed colleagues such as Gabriele Winter and Heike Neumann, contributing to the advancement of pharmaceutical sciences through teamwork and shared expertise.
Conclusion
Michael Formell's contributions to pharmaceutical innovations highlight his commitment to improving healthcare through effective medication delivery systems. His work continues to impact the field positively.